Buscar Close Search
Buscar Close Search
Page Menu

"Speaking of Vitiligo..."

I am a physician-scientist who focuses my clinical and research efforts on vitiligoI am a physician-scientist who focuses my clinical and research efforts on vitiligo, and therefore I think about this disease a lot – all the time, in fact. Therefore I thought it would be helpful to share my thoughts with others who are interested in vitiligo as well, particularly the patients who suffer from it and their loved ones. I want to make clear that while I am affiliated with many vitiligo organizations, my comments in this blog are my own, and do not reflect the opinions of those organizations. In addition, my research is largely focused on finding new treatments, and ultimately a cure, for vitiligo. This work is supported by a number of sources, including pharmaceutical companies, which by definition creates potential conflicts of interest. In full disclosure, here is a list of our vitiligo research supporters. Please know that, to the best of my ability, all of my comments are unbiased reflections of my understanding of vitiligo as both a physician and scientist. I do not permit advertisements on my website, and do not endorse companies or products that may advertise on other sites that may be referenced here.

A New Hope for Repigmentation: JAK Inhibitors and Vitiligo

Posted On: jueves, junio 06, 2024

Janus kinase (JAK) inhibitors are a class of medications that target specific enzymes (JAK proteins) involved in signaling pathways that drive the immune system. By inhibiting these enzymes, JAK inhibitors can modulate the immune response, making them effective in treating various inflammatory conditions.

Comments count

The Future of Vitiligo Research is Now: A Look Back at the VCORT Symposium

Posted On: lunes, marzo 04, 2024

The VIGOR study is just one of the groundbreaking initiatives in vitiligo research happening at UMass Chan Medical School. Many of the VIGOR researchers, plus several others recently gathered for the first annual Vitiligo Center of Research Translation (VCORT) Symposium held at UMass Chan Medical School in Worcester, MA.

Comments count

Bill H.976: Expanding Vitiligo Treatment Access for All

Posted On: sábado, julio 01, 2023

This week I had the privilege of visiting the Massachusetts State House for an indoor rally hosted by VITFriends, a non-profit vitiligo patient advocacy group whose focus is to bring the vitiligo community together and raise awareness about vitiligo. I met with many members of the community, and we were joined by State Representative Rob Consalvo to talk about advances in vitiligo.

Comments count

A Breakthrough in Skin Disease Advances Treatment Options for Autoimmunity

Posted On: lunes, mayo 15, 2023

Dr. John Harris discusses breakthroughs in vitiligo and how they've helped advance treatment options for many autoimmune diseases

Comments count

Opzelura, the first FDA-approved drug to treat vitiligo!

Posted On: lunes, julio 18, 2022

Opzelura was already approved last September, 2021, for a disease called atopic dermatitis, or eczema, so you may have already seen it in the pharmacy. But most couldn’t get it covered by insurance for vitiligo because it wasn’t approved for it, and so NOW IT IS!

Comments count

Vitiligo Repigmentation Study Opportunity

Posted On: lunes, noviembre 29, 2021

rsvp-study-bring-pigment-back.jpg

RSVP study is specifically for those who have treatment-resistant vitiligo that is STABLE, or not changing for at least 1 year. The process being tested is to transplant pigment cells from one part of the body without vitiligo to another part that is affected by vitiligo.

Comments count

Phase 3 vitiligo clinical trial results to test topical ruxolitinib as a new treatment

Posted On: martes, junio 22, 2021

Incyte decided to run a Phase 3 Clinical Trial in over 600 patients all over the world, with the goal of supporting an application to the FDA (and the European equivalent, the EMA) to approve the treatment for patients. This means it would be available for prescription from the pharmacy, and should be covered by health insurance companies, as it would become the first and only FDA-approved treatment to reverse the effects of vitiligo! Well, we recently heard (although the data isn’t publicly available yet) that the results of the Phase 3 trial were excellent!

Comments count

IN HIS WORDS – Dr. Amit Pandya

Posted On: martes, abril 06, 2021

Vitiligo’s crystal ball

One of the frustrating aspects of vitiligo is its unpredictability. It’s hard to know when it will become active and when it will be stable. Individuals with vitiligo tell me they often worry about waking up and finding a new spot on their skin. They worry about the future and wonder if their vitiligo will get worse. But what if there was a crystal ball that could tell you what was in your future?

Comments count

COVID Vaccination and Vitiligo

Posted On: sábado, enero 02, 2021

happy-new-year.jpg

2020 was a difficult year for so many of us, with COVID-19 creating a pandemic that we have not seen for over 100 years. In the spring, many wondered how having vitiligo would influence the effect of the virus, such as getting more severe effects from the virus, or whether vitiligo might get worse during an infection with it.

Comments count

Patterns of Vitiligo

Posted On: viernes, mayo 29, 2020

I have always thought that vitiligo was beautiful, including the many patterns that form on individuals with different skin colors, shades, and hues. Vitiligo can appear on any part of the body, in many different shapes and forms. It is most frequent on the face and genitals, then the hands and feet, and then the rest of the body. One woman outlined all of her spots with a pen, which I thought was really cool and I included her picture in my blog about vitiligo and tattoos here (with her permission, of course). Since I have seen many patients over many thousands of visits in my Vitiligo Clinic, I have seen a LOT of patterns, but I still see new ones all the time. It’s one of the things that makes my job a whole lot of fun!

Comments count
1-10  of  38  items
of 4